Sinobioway Cell Therapy Co., Ltd.
7 clinical trials · Sponsor
◉ Watch Sinobioway Cell Therapy Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| CAR-T Treatment for Relapse / Refractory Type Safety and Effectiveness of Lymphoma (NCT03488160) | Sinobioway Cell Therapy Co., Ltd. | 2018-04-10 |
Track Sinobioway Cell Therapy Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.